Literature DB >> 2206213

The role of myc oncogenes in cell growth and differentiation.

T D Littlewood1, G I Evan.   

Abstract

The myc oncoproteins are expressed in a wide range of normal adult and embryonic tissues. They are also found to be over-expressed in a variety of tumor types. All myc proteins are short-lived nuclear phosphoproteins thought to act as regulatory components of cell proliferation. The rapid induction of c-myc mRNA and protein following the addition of growth factors to quiescent cells, together with the short half-life of these molecules, suggests that they are sensitive and continuous indicators of external stimuli, consistent with a role in signal transduction. Furthermore, in untransformed cells, c-myc protein expression is tightly regulated, at least in part, by a mechanism of autoregulation. Deregulated expression of myc genes is a frequent observation in tumors and may lead to a cell becoming independent of one or more growth factors, with the concomitant potential for uncontrolled proliferation. Although the precise functions of the myc proteins are unknown, they all bear the hallmarks of multimeric DNA-binding proteins probably involved in the regulation of expression of specific genes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2206213     DOI: 10.1177/08959374900040011001

Source DB:  PubMed          Journal:  Adv Dent Res        ISSN: 0895-9374


  9 in total

1.  Myc: the beauty and the beast.

Authors:  Amanda R Wasylishen; Linda Z Penn
Journal:  Genes Cancer       Date:  2010-06

2.  Stabilization of c-myc protein in human glioma cells.

Authors:  H Shindo; E Tani; T Matsumuto; T Hashimoto; J Furuyama
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

3.  Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase.

Authors:  J Yu; C Angelin-Duclos; J Greenwood; J Liao; K Calame
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

4.  Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments.

Authors:  Rosa-Maria Ferraiuolo; Bre-Anne Fifield; Caroline Hamm; Lisa A Porter
Journal:  Breast Cancer Res Treat       Date:  2022-08-27       Impact factor: 4.624

5.  The nephrotoxin dichlorovinylcysteine induces expression of the protooncogenes c-fos and c-myc in LLC-PK1 cells--a comparative investigation with growth factors and 12-O-tetradecanoylphorbolacetate.

Authors:  S Vamvakas; U Köster
Journal:  Cell Biol Toxicol       Date:  1993 Jan-Mar       Impact factor: 6.691

6.  The proto-oncogene C-raf-1 is highly expressed only in the hypertrophic zone of the growth plate.

Authors:  Y Kaneko; H Tanzawa; K Sato
Journal:  Calcif Tissue Int       Date:  1994-05       Impact factor: 4.333

7.  Cdk5-mediated phosphorylation of c-Myc on Ser-62 is essential in transcriptional activation of cyclin B1 by cyclin G1.

Authors:  Haeng Ran Seo; Joon Kim; Sangwoo Bae; Jae-Won Soh; Yun-Sil Lee
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

8.  The c-MYC protooncogene expression in cholesteatoma.

Authors:  Enikő Palkó; Szilárd Póliska; Zsuzsanna Csákányi; Gábor Katona; Tamás Karosi; Frigyes Helfferich; András Penyige; István Sziklai
Journal:  Biomed Res Int       Date:  2014-02-10       Impact factor: 3.411

Review 9.  Emerging Roles of lncRNAs in the Formation and Progression of Colorectal Cancer.

Authors:  Qinglian He; Jiali Long; Yuting Yin; Yuling Li; Xue Lei; Ziqi Li; Wei Zhu
Journal:  Front Oncol       Date:  2020-01-17       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.